• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[环丙沙星与β-内酰胺类抗生素、庆大霉素、米诺环素及吡哌酸的协同作用]

[Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].

作者信息

Dickgiesser N, in der Stroth S, Wundt W

出版信息

Infection. 1986 Mar-Apr;14(2):82-5. doi: 10.1007/BF01644449.

DOI:10.1007/BF01644449
PMID:2940188
Abstract

Studies on the Synergism of Ciprofloxacin with beta-Lactam Antibiotics, Gentamicin, Minocycline and Pipemidic Acid. Using Escherichia coli, Klebsiella pneumoniae/Klebsiella oxytoca, Pseudomonas aeruginosa and Staphylococcus aureus strains, we examined a possible influence of pipemidic acid, minocycline, gentamicin, cefazolin, mezlocillin and ampicillin on the antibiotic activity of ciprofloxacin. We found in all bacterial species synergistic influence by pipemidic acid. When ciprofloxacin was combined with gentamicin, synergism was observed in E. coli and in K. pneumoniae/oxytoca, additive effects in P. aeruginosa and S. aureus. In combination with minocycline we demonstrated synergism in S. aureus only. In all other bacterial species and antibiotic combinations we found neither synergism nor antagonism.

摘要

环丙沙星与β-内酰胺类抗生素、庆大霉素、米诺环素和吡哌酸协同作用的研究。我们使用大肠杆菌、肺炎克雷伯菌/产酸克雷伯菌、铜绿假单胞菌和金黄色葡萄球菌菌株,研究了吡哌酸、米诺环素、庆大霉素、头孢唑林、美洛西林和氨苄西林对环丙沙星抗菌活性的可能影响。我们发现在所有细菌种类中,吡哌酸都有协同作用。当环丙沙星与庆大霉素联合使用时,在大肠杆菌和肺炎克雷伯菌/产酸克雷伯菌中观察到协同作用,在铜绿假单胞菌和金黄色葡萄球菌中观察到相加作用。与米诺环素联合使用时,仅在金黄色葡萄球菌中表现出协同作用。在所有其他细菌种类和抗生素组合中,我们既未发现协同作用也未发现拮抗作用。

相似文献

1
[Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].[环丙沙星与β-内酰胺类抗生素、庆大霉素、米诺环素及吡哌酸的协同作用]
Infection. 1986 Mar-Apr;14(2):82-5. doi: 10.1007/BF01644449.
2
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.环丙沙星(拜奥9867)、诺氟沙星、吡哌酸和萘啶酸的比较活性。
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4. doi: 10.1128/AAC.24.2.302.
3
[In vitro antimicrobial activity of pipemidic acid on strains isolated from urine cultures of hospitalized and nonhospitalized subjects].吡哌酸对住院和非住院患者尿培养分离菌株的体外抗菌活性
Boll Soc Ital Biol Sper. 1980 Aug 30;56(16):1629-32.
4
The effect of combinations of a glyphosate-based herbicide with various clinically used antibiotics on phenotypic traits of Gram-negative species from the ESKAPEE group.草甘膦除草剂与各种临床使用的抗生素组合对 ESKAPEE 组革兰氏阴性菌表型特征的影响。
Sci Rep. 2024 Sep 9;14(1):21006. doi: 10.1038/s41598-024-68968-6.
5
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.环丙沙星与其他药物对近期医院分离株的体外活性比较。
Chemioterapia. 1986 Apr;5(2):75-82.
6
[Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].吡哌酸与萘啶酸的体外抗菌活性(作者译)
Dtsch Med Wochenschr. 1979 Jun 29;104(26):946-8. doi: 10.1055/s-0028-1104021.
7
Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.环丙沙星在血清和尿液中对大肠杆菌、铜绿假单胞菌、肺炎克雷伯菌、金黄色葡萄球菌和粪肠球菌的杀菌活性。
J Antimicrob Chemother. 1985 Sep;16(3):341-7. doi: 10.1093/jac/16.3.341.
8
Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.阿米氟沙星对明确的耐庆大霉素革兰氏阴性菌的活性。
Antimicrob Agents Chemother. 1984 Nov;26(5):781-4. doi: 10.1128/AAC.26.5.781.
9
Clinical studies on pipemidic acid.吡哌酸的临床研究
Jpn J Antibiot. 1978 Sep;31(9):528-35.
10
[Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Pathol Biol (Paris). 1987 May;35(5):467-72.

本文引用的文献

1
In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.利福平与苯唑西林联合对金黄色葡萄球菌的体外活性
Antimicrob Agents Chemother. 1983 Apr;23(4):571-6. doi: 10.1128/AAC.23.4.571.
2
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.在中性粒细胞减少部位兔模型中,阿洛西林、头孢唑肟、头孢西丁和阿米卡星单独及联合应用对铜绿假单胞菌的比较。
Antimicrob Agents Chemother. 1984 May;25(5):545-52. doi: 10.1128/AAC.25.5.545.
3
[Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
[莫西拉坦和头孢噻肟——两种新型β-内酰胺抗生素与三种知名头孢菌素的比较]
Arzneimittelforschung. 1981;31(10):1677-81.
4
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.环丙沙星,一种对需氧菌和厌氧菌均有活性的喹诺酮羧酸化合物。
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26. doi: 10.1128/AAC.25.3.319.
5
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星(拜耳o 9867)的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
6
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.环丙沙星、诺氟沙星和萘啶酸的体外活性。
Eur J Clin Microbiol. 1983 Apr;2(2):111-5. doi: 10.1007/BF02001575.
7
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.新型喹啉衍生物Bay 09867与其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
8
[Mode of action and mechanisms of resistance of gyrase inhibitors].
Immun Infekt. 1984 Nov;12(6):298-302.